Paul Grootendorst

Paul Grootendorst is an Adjunct Associate Professor in the Department of Economics at McMaster University, with a focus on health economics and pharmaceutical policy. His work bridges economic theory with real-world healthcare challenges, emphasizing policy evaluation and cost-effectiveness analysis.

• Key Research Areas: Pharmaceutical pricing, biosimilars, medical cannabis, vaccine ecosystems, drug reimbursement policies, and health equity.
• Recent Publications: Analyze Canadian pharmaceutical policies, including biosimilar market penetration, cannabis legalization impacts, and tiered pricing frameworks. His 2024-2025 studies span dental care access, anti-TNF biosimilars, and alcohol substitution effects post-legalization.
• Methodological Expertise: Instrumental variables, propensity score modeling, systematic reviews, and simulation studies applied to health data.